NOTCH1 and head and neck squamous cell carcinoma: Previous research from our group used an unbiased pharmacogenomics approach and identified a remarkable correlation between NOTCH1 LOF mutations and sensitivity to PI3K inhibitors in HNSCC cell lines [87].